Эпидемиология и вакцинопрофилактика (Jul 2022)

The prevalence of viral hepatitis D in the world

  • V. G. Akimkin,
  • Z. B. Ponezheva,
  • Kh. G. Omarova,
  • Yu. А. Goloverova,
  • S. V. Ugleva,
  • S. V. Shabalina

DOI
https://doi.org/10.31631/2073-3046-2022-21-3-90-95
Journal volume & issue
Vol. 21, no. 3
pp. 90 – 95

Abstract

Read online

Relevance According to many researchers, hepatitis D worsens the prognosis of hepatitis B in 80–90% of cases, accelerating fibrosis and leading to liver cirrhosis or hepatocellular carcinoma. Aims. To present a review of data on prevalence of hepatitis D in the Russian Federation and abroad. Conclusions. Hepatitis D is most common in such regions of the world as: Africa, South America, Middle East, North Asia and in some Mediterranean countries. Conclusions. Injecting drug users play a large role among vulnerable populations. Hepatitis B vaccination limits the spread of hepatitis D.

Keywords